Canada Spends Logo

Explorez notre analyse du budget 2026

Grant: Collaborative Health Research Projects

University of Toronto

$66,500.00

Investigation of mesenchymal progenitor cell response to mechanobiological stimuli using novel MEMS-based array platform

EF 2006-07

Résumé
Cardiovascular and musculoskeletal disorders are amongst the most important health care challenges facing Canada and other developed nations. They also represent the most common targets for emerging cell-based therapies that use mesenchymal stem cells (MSCs) to regenerate diseased or damaged tissue. MSCs are a promising cell source because they can differentiate or mature to functional cells that can repair many different types of tissue, including heart muscle, heart valves, bone, cartilage, muscle, and tendons and ligaments. However, before stem cells can be used therapeutically, strategies to control their growth and to direct their maturation to functional cells need to be identified and developed. The overall goal of this collaborative health research project is to screen various regulatory factors for their ability to control the growth and function of a promising new human stem cell population that we discovered in umbilical cord tissue. We will evaluate the abilities of various chemicals and matrix proteins to regulate MSC behaviour, but also will consider the effects of mechanical forces. Mechanical stimulation is believed to be important to create cells that can regenerate tissues that normally are mechanically active, like heart valves, bones, or muscles. In order to efficiently screen the combined effects of chemical, matrix, and mechanical factors on stem cell growth and differentiation, we will develop a new microscale device that will allow us to test multiple combinations of factors on hundreds of samples simultaneously at a higher rate and lower cost than is possible currently. We anticipate this technology and its application to study stem cells will speed discovery and innovation in the field of regenerative medicine, ultimately leading to improved cell-based therapies that will improve the health of Canadians. These collaborative studies will additionally provide students with high level multidisciplinary training, preparing them for careers in biomedical engineering and biotechnology.
Programme
Collaborative Health Research Projects
Bénéficiaire
Emplacement
Ontario, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
NSERC's Awards Data

Tel que publié

Application id
323533-2006
Name nom
Simmons, Craig
Department département
Mechanical and Industrial Engineering
Organization id
31
Institution établissement
University of Toronto
Province en
Ontario
Province fr
Ontario
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2006
Competition year année de concours
2006
Award amount
66500
Program id
CHRPJ
Program name en
Collaborative Health Research Projects
Program name fr
Projets de recherche concertée sur la santé
Group en
Discovery grants programs
Group fr
Programmes de subventions à la découverte
Committee code
360
Committee name en
Collaborative Health Research Projects Selection Panel
Committee name fr
Comité de sélection de projets de recherche concertée sur la santé
Area of application code
1102
Area of application group en
Health, education and social services
Area of application group fr
Santé publique, éducation et services sociaux
Area of application en
Biomedical engineering
Area of application fr
Génie biomédical
Research subject code
1900
Research subject group en
Biomedical engineering
Research subject group fr
Génie biomédical
Research subject en
Biomedical engineering
Research subject fr
Génie biomédical
Partie
1
Nb partie
3
Application title
Investigation of mesenchymal progenitor cell response to mechanobiological stimuli using novel MEMS-based array platform
Keyword
NA
Application summary
Cardiovascular and musculoskeletal disorders are amongst the most important health care challenges facing Canada and other developed nations. They also represent the most common targets for emerging cell-based therapies that use mesenchymal stem cells (MSCs) to regenerate diseased or damaged tissue. MSCs are a promising cell source because they can differentiate or mature to functional cells that can repair many different types of tissue, including heart muscle, heart valves, bone, cartilage, muscle, and tendons and ligaments. However, before stem cells can be used therapeutically, strategies to control their growth and to direct their maturation to functional cells need to be identified and developed. The overall goal of this collaborative health research project is to screen various regulatory factors for their ability to control the growth and function of a promising new human stem cell population that we discovered in umbilical cord tissue. We will evaluate the abilities of various chemicals and matrix proteins to regulate MSC behaviour, but also will consider the effects of mechanical forces. Mechanical stimulation is believed to be important to create cells that can regenerate tissues that normally are mechanically active, like heart valves, bones, or muscles. In order to efficiently screen the combined effects of chemical, matrix, and mechanical factors on stem cell growth and differentiation, we will develop a new microscale device that will allow us to test multiple combinations of factors on hundreds of samples simultaneously at a higher rate and lower cost than is possible currently. We anticipate this technology and its application to study stem cells will speed discovery and innovation in the field of regenerative medicine, ultimately leading to improved cell-based therapies that will improve the health of Canadians. These collaborative studies will additionally provide students with high level multidisciplinary training, preparing them for careers in biomedical engineering and biotechnology.